Abstract
Background Catheterization facilitates continuous bacteriuria, for which the clinical significance remains unclear. This study aimed to determine the clinical presentation, epidemiology, and dynamics of bacteriuria in a cohort of long-term catheterized nursing home residents.
Methods Prospective urine culture, urinalysis, chart review, and assessment of signs and symptoms of infection were performed weekly for 19 study participants over 7 months. All bacteria ≥103 cfu/ml were cultured, isolated, identified, and tested for susceptibility to select antimicrobials.
Results 226 of the 234 urines were polymicrobial (97%), with an average of 4.7 isolates per weekly specimen. 228 urines (97%) exhibited ≥106 CFU/ml, 220 (94%) exhibited abnormal urinalysis, 126 (54%) were associated with at least one possible sign or symptom of infection, 82 (35%) would potentially meet a standardized definition of CAUTI, but only 3 had a caregiver diagnosis of CAUTI. 286 (30%) of bacterial isolates were resistant to a tested antimicrobial agent, and bacteriuria composition was remarkably stable despite a combined total of 54 catheter changes and 23 weeks of antimicrobial use.
Conclusions Bacteriuria composition was largely polymicrobial, including persistent colonization by organisms previously considered to be urine culture contaminants. Neither antimicrobial use nor catheter changes sterilized the urine, at most resulting in transient reductions in bacterial burden followed by new acquisition of resistant isolates. Thus, this patient population exhibits a high prevalence of bacteriuria coupled with potential indicators of infection, necessitating further exploration to identify sensitive markers of true infection.
Funding This work was supported by the NIH (R00 DK105205, R01 DK123158, UL1 TR001412)
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This was an observational study without any intervention
Funding Statement
This work was supported by the National Institutes of Health via the National Institute of Diabetes Digestive and Kidney Diseases [R00 DK105205 and R01 DK123158 to C.E.A.] and the National Center for Advancing Translational Sciences (UL1 TR001412 to the University at Buffalo). The sponsors were not involved in the study design, methods, subject recruitment, data collections, analysis, or preparation of the paper. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the University at Buffalo Institutional Review Board (STUDY00002526) and complied with the provisions of the Declaration of Helsinki, Good Clinical Practice guidelines, and local laws and regulations.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Based on external review, the figures, tables, and supplemental files have been revised to display four examples of the complete longitudinal data (urine culture composition, signs and symptoms, and urinalysis findings) as Figure 1, an overview of the number of organisms present at all study visits and the impact of catheter changes and antibiotic use on colonization density as Figure 2, and the full urine culture composition, sign and symptom dynamics, and urinalysis findings as additional supplemental figures. We have also included rigorous statistical analyses, including computation of Lin concordance correlation coefficient to identify highly concordant co-colonization partners and to determine concordance of all possible signs and symptoms of infection. Furthermore, we have included new multivariate Bayesian multilevel models to determine the contribution of catheter changes, antibiotic use, presence of specific microbes, and presence of specific signs or symptoms of infection at one study visit to the likelihood of a specific microbe or infection sign/symptom being present at the following study visit. Using this approach, we demonstrate that neither catheter changes nor antibiotics significantly reduce colonization by any specific microbe or the total number of colonizing microbes, and instead reveal a trend towards increased incidence of colonization.
Data Availability
All data are provided within the manuscript and supplemental files.
